查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1490094

适体市场：按类型、按应用、按最终用户、按地区

Aptamers Market, By Type, By Application, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2024年全球适配体市场规模为72.9亿美元，预计2031年将达229.3亿美元，2024年至2031年复合年增长率为17.8%。

报告范围 报告详情
基准年 2023年 2024年市场规模 72.9亿美元
实际资料 2019-2023 预测期 2024年至2031年
预测 2024-2031 年复合年增长率： 17.80% 2031年价值预测 229.3亿美元
图：2024 年按地区分類的适体市场占有率(%)
适体市场-IMG1

适体是与特定标靶分子结合的单链去氧核糖核酸(DNA) 或核糖核酸 (RNA) 分子。适配体可以化学合成，并以高亲和性和特异性识别并结合蛋白质、小分子和细胞表面标靶分子。与抗体相比，适体具有体积小、易于製造和修饰、非免疫抗原性、组织穿透性高等优点。适体应用于研究、诊断和治疗等广泛领域。

市场动态：

全球适体市场的成长是由生命科学和製药业不断增加的研发投资所推动的。此外，由于其优势，适体越来越多地被用作诊断和研究中抗体的替代品，推动市场成长。然而，与适体开发和生产相关的高成本是阻碍市场成长的主要因素。新技术的出现使生产适配体变得更加容易且更具成本效益，这为市场相关人员提供了重大机会。

本研究的主要特点

  • 该报告对全球适配体市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
  • 它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
  • 该报告根据公司亮点、产品系列、主要亮点、业绩和策略等参数，提供了全球适体市场主要企业的概况。
  • 该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
  • 全球适体市场迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 透过分析全球适体市场时所使用的各种策略矩阵，促进相关人员的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章 市场动态、法规与趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 主要进展
  • 监管场景
  • 製造商收益
  • 收购和合作场景
  • 产品发布/核准
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

第四章全球适体市场－冠状病毒（COVID-19）大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 对市场的影响

第五章全球适体市场，依类型，2019-2031

  • 核酸
  • 基于 DNA 的适体
  • 基于 RNA 的适体
  • 基于 XNA 的适体
  • 胜胜肽适体

第六章全球适体市场，依应用分类，2019-2031

  • 诊断
  • 治疗
  • 研究与开发

第 7 章 全球适体市场，依最终使用者划分，2019-2031 年

  • 生物技术和製药公司
  • 学术研究所
  • 合约研究组织

第八章全球适体市场，按地区，2019-2031

第9章 竞争格局

  • 公司简介
    • AstraZeneca
    • Achiko AG
    • Agilent Technologies, Inc.
    • Amsbio
    • Aptagen LLC
    • Aptamer Group
    • CAGE Bio Inc.
    • GC Biopharma Corp.
    • GlyTech, Inc.
    • IVERIC bio, Inc.
    • NeoNeuro SAS
    • Novartis AG
    • Ophthotech Corporation
    • SomaLogic Operating Co., Inc.
    • TAGCyx Biotechnologies Inc.
    • Vivonics Inc.
    • Zentek Ltd.

第10章分析师建议

  • Wheel of Fortune
  • 分析师观点
  • Coherent Opportunity Map

第十一章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI774

Global aptamers market is estimated to be valued at USD 7.29 Bn in 2024 and is expected to reach USD 22.93 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 17.8% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 7.29 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 17.80% 2031 Value Projection: US$ 22.93 Bn
Figure. Aptamers Market Share (%), By Region, 2024
Aptamers Market - IMG1

Aptamers are single stranded Deoxyribonucleic acid (DNA) or Ribonucleic acid (RNA) molecules that bind to a specific target molecule. These can be chemically synthesized to recognize and bind protein, small molecule or cell surface targets with high affinity and specificity. Aptamers have several advantages over antibodies such as small size, easy production and modification, lack of immunogenicity and better tissue penetration. These have wide applications in research, diagnostics, therapeutics and others.

Market Dynamics:

Global aptamers market growth is driven by rising research and development investments in life sciences and pharmaceutical industries. Growing use of aptamers as an alternative to antibodies in diagnostics and research due to their advantages is also boosting the market growth. However, high costs associated with aptamer development and production is a major factor hampering the market growth. Emergence of novel technologies for simpler and cost-effective production of aptamers provides a significant opportunity for market players.

Key Features of the Study:

  • This report provides in-depth analysis of the global aptamers market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global aptamers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study AstraZeneca, Achiko AG, Agilent Technologies, Inc., Amsbio, Aptagen LLC, Aptamer Group, CAGE Bio Inc., GC Biopharma Corp., GlyTech, Inc., IVERIC bio, Inc., NeoNeuro SAS, Novartis AG, Ophthotech Corporation, SomaLogic Operating Co., Inc., TAGCyx Biotechnologies Inc., Vivonics Inc., Zentek Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global aptamers market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aptamers market.

Detailed Segmentation-

  • By Type:
    • Nucleic Acid
    • DNA-based Aptamers
    • RNA-based Aptamers
    • XNA-based Aptamers
    • Peptide Aptamers
  • By Application:
    • Diagnostics
    • Therapeutics
    • Research and Development
  • By End User:
    • Biotechnology and Pharmaceutical Companies
    • Academic and Research Institutions
    • Contract Research Organization
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • AstraZeneca
    • Achiko AG
    • Agilent Technologies, Inc.
    • Amsbio
    • Aptagen LLC,
    • Aptamer Sciences, Inc.
    • CAGE Bio Inc.
    • GC Biopharma Corp.
    • GlyTech, Inc.
    • IVERIC bio, Inc.
    • NeoNeuro SAS
    • Novartis AG
    • Ophthotech Corporation
    • SomaLogic Operating Co., Inc.
    • TAGCyx Biotechnologies Inc.
    • Vivonics Inc.
    • Zentek Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Manufacturer Revenue
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Aptamers Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the market

5. Global Aptamers Market, By Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Nucleic Acid
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • DNA-based Aptamers
  • RNA-based Aptamers
  • XNA-based Aptamers
  • Peptide Aptamers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Aptamers Market, By Application, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Diagnostics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Therapeutics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Research and Development
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Aptamers Market, By End User, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Biotechnology and Pharmaceutical Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Academic and Research Institutions
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Contract Research Organization
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Aptamers Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
      • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
      • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
      • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
      • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • AstraZeneca
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Achiko AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Agilent Technologies, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Amsbio
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Aptagen LLC
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Aptamer Group
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • CAGE Bio Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GC Biopharma Corp.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GlyTech, Inc.
    • IVERIC bio, Inc.
    • NeoNeuro SAS
    • Novartis AG
    • Ophthotech Corporation
    • SomaLogic Operating Co., Inc.
    • TAGCyx Biotechnologies Inc.
    • Vivonics Inc.
    • Zentek Ltd.

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact